Cargando…
High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
PURPOSE: Cyclin D1 has a central role in cell cycle control and is an important component of estrogen regulation of cell cycle progression. We have previously shown that high cyclin D expression is related to aggressive features of ER-positive but not ER-negative breast cancer. The aims of the prese...
Autores principales: | Ahlin, Cecilia, Lundgren, Claudia, Embretsén-Varro, Elin, Jirström, Karin, Blomqvist, Carl, Fjällskog, M. -L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495873/ https://www.ncbi.nlm.nih.gov/pubmed/28528450 http://dx.doi.org/10.1007/s10549-017-4294-5 |
Ejemplares similares
-
Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides
por: Aaltonen, K, et al.
Publicado: (2006) -
Clinical significance of stromal ER and PR expression in periampullary adenocarcinoma
por: Andersson, Gustav, et al.
Publicado: (2019) -
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study
por: Iwata, Hiroji, et al.
Publicado: (2018) -
ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer
por: Reese, Jordan M., et al.
Publicado: (2017) -
Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer
por: Haddad, Tufia C., et al.
Publicado: (2017)